ML24100A025: Difference between revisions
StriderTol (talk | contribs) (StriderTol Bot insert) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
| Line 23: | Line 23: | ||
==Purpose:== | ==Purpose:== | ||
Provide an opportunity to hear views from the Advisory Committ ee on the Medical Uses of Isotopes (ACMUI) on medical-related topics of r | Provide an opportunity to hear views from the Advisory Committ ee on the Medical Uses of Isotopes (ACMUI) on medical-related topics of r egulatory interest. | ||
Scheduled: | Scheduled: April 9, 2024 10:00 am | ||
Duration: | Duration: Approximately 2 hours | ||
Location: | Location: Commissioners Hearing Room, 1 st floor OWFN | ||
Panel | Panel 60 mins* | ||
Hossein Jadvar, M.D., Ph.D., ACMUI Chair Topic: | Hossein Jadvar, M.D., Ph.D., ACMUI Chair Topic: | ||
| Line 40: | Line 40: | ||
Megan Shober, ACMUI Agreement State Representative Topic: | Megan Shober, ACMUI Agreement State Representative Topic: | ||
* ACMUI Comments on Revisions to Regulatory Guide 8.39, Release | * ACMUI Comments on Revisions to Regulatory Guide 8.39, Release of Patients Administered Radioactive Material | ||
Josh Mailman, ACMUI Patients' Rights Advocate Topic: | Josh Mailman, ACMUI Patients' Rights Advocate Topic: | ||
* Patients Rights Advocates Perspectives on: | * Patients Rights Advocates Perspectives on: | ||
o | o Regulatory Guide 8.39, Release of Patients Administered Radioactive Material o Reporting of Nuclear Medicine Injection Extravasations | ||
Commission Q & A | Commission Q & A 40 mins. | ||
Discussion - Wrap-Up | Discussion - Wrap-Up 5 mins. | ||
*For presentation only and does not include time for Commission | *For presentation only and does not include time for Commission Q & A}} | ||
Revision as of 18:07, 4 October 2024
| ML24100A025 | |
| Person / Time | |
|---|---|
| Issue date: | 04/09/2024 |
| From: | NRC/OCM |
| To: | |
| Shared Package | |
| ML24060A004 | List: |
| References | |
| M240409B | |
| Download: ML24100A025 (1) | |
Text
AGENDA
Title:
MEETING WITH THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES (Public Meeting)
Purpose:
Provide an opportunity to hear views from the Advisory Committ ee on the Medical Uses of Isotopes (ACMUI) on medical-related topics of r egulatory interest.
Scheduled: April 9, 2024 10:00 am
Duration: Approximately 2 hours2.314815e-5 days <br />5.555556e-4 hours <br />3.306878e-6 weeks <br />7.61e-7 months <br />
Location: Commissioners Hearing Room, 1 st floor OWFN
Panel 60 mins*
Hossein Jadvar, M.D., Ph.D., ACMUI Chair Topic:
- Overview of ACMUI activities
Richard Harvey, DrPH, ACMUI Radiation Safety Officer Representative Topic:
- ACMUIs Review and Analysis of Reported Medical Events from Fiscal Years 2021-2023
Megan Shober, ACMUI Agreement State Representative Topic:
- ACMUI Comments on Revisions to Regulatory Guide 8.39, Release of Patients Administered Radioactive Material
Josh Mailman, ACMUI Patients' Rights Advocate Topic:
- Patients Rights Advocates Perspectives on:
o Regulatory Guide 8.39, Release of Patients Administered Radioactive Material o Reporting of Nuclear Medicine Injection Extravasations
Commission Q & A 40 mins.
Discussion - Wrap-Up 5 mins.
- For presentation only and does not include time for Commission Q & A